SFAK20002U Cancelled Advanced Manufacturing of Pharmaceuticals

Volume 2021/2022
Education

MSc Programme in Pharmacy (Danish programmes cand.pharm) - elective

MSc Programme in Pharmaceutical Sciences (Danish programmes  cand.scient.pharm) - restricted elective

MSc Programme in Medicinal Chemistry - elective

MSc Programme in Pharmaceutical Sciences (English programme) - restricted elective

 

Content

The course will introduce the critical tools needed for future professionals working in drug development and manufacturing of pharmaceuticals. The main goal is to provide students with knowledge required for designing robust medicinal product using Quality by Design (QbD) principles. The course will start by introducing the unit operations used in manufacturing of pharmaceuticals. This part covers primary manufacturing of both small molecules (synthesis and crystallization) as well as biologics (fermentation and related separation technologies), followed by introduction of secondary manufacturing steps (granulation, tableting and coating), as well as spray/freeze drying technologies for biologics. Special focus will be on introducing enabling manufacturing solutions for nanomedicine. Theory and practice will be introduced hand in hand with lectures and excursions to local industry including examples from both small molecule and biologics. Next phase involves the introduction of central Quality by Design tools - Design of Experiments (DoE) and chemometrics, as well as physical modelling of system behavior. Students will be introduced to different levels of modelling used in designing robust manufacturing processes – starting from modelling molecular interactions explaining the behaviour of systems with pharmaceutical interest, and proceeding to modelling of process performance based on engineering principles. Specific examples of process analytical technologies (PAT) will be discussed with a special focus on analytical tools applicable for the analysis of moving matter. The last part of the course provides deeper insight into the general structure of pharmaceutical quality systems and risk management approaches. Principles of the plant design of pharmaceutical manufacturing sites will be introduced. For project work, students will work in small groups of 4 students around given formulation/processing example. Project work will be presented during project presentation.

Learning Outcome

To provide students with fundamental knowledge related to manufacturing of pharmaceuticals. Participants will gain deeper insight into all critical unit operations of pharmaceutical interest, as well as an introduction to functions of pharmaceutical quality systems and plant design principles. All this will be introduced as a sound combination of lectures and excursions to local industry. The Quality by Design (QbD) approach will be a key element in the course. Design of Experiments (DoE) and chemometrics, as well as physical modelling will be explained through lectures and practical exercises. After finishing the course, students should also be able to use the physicochemical principles to analyse the processability of a given dosage form.

At the end of the course, students are expected to be able to:

Knowledge

  • analyse the critical unit operations used in manufacturing of small molecule and biologics based medicinal products
  • understand the importance of formulation design in relation to manufacturing according to Quality by Design (QbD) principles
  • demonstrate insight into pharmaceutical quality systems, risk management techniques and plant design of pharmaceutical manufacturing sites

 

Skills

  • perform Design of Experiments (DoE) and multivariate data analysis
  • construct risk assessment of a given pharmaceutical product
  • apply the general principles of physical modelling related to manufacturing of pharmaceuticals.

 

Competences

  • understand the importance of imlementing Quality by Design (QbD) principles into drug development
  • have acquired skills to implement basic elements of QbD into formulation design and manufacturing of a pharmaceutical product

Lecture notes and relevant publications are available from the course homepage.

Students are expected to have a good knowledge of formulation and processing of dosage forms, as well as an interest in becoming a future specialist in the field of pharmaceutical development.
Theory and practice will be introduced hand in hand with lectures and excursions to local industry including examples from both small molecule and biologics. For project work, students will work in small groups of 4 students around given formulation/processing example. Project work will be presented during project presentation.

•Lectures: 30 hours
•Excursions: 12 hours
•Seminar: 4 hours
  • Category
  • Hours
  • Lectures
  • 30
  • Class Instruction
  • 4
  • Preparation
  • 84
  • Excursions
  • 12
  • Project work
  • 76
  • Total
  • 206
Oral
Individual
Collective
Continuous feedback during the course of the semester
Credit
7,5 ECTS
Type of assessment
Course participation
Course certificate:
The student will achieve a course certificate when participation satisfactory during the lectures, exercises, project work and project presentation.
Marking scale
passed/not passed
Censorship form
No external censorship
Criteria for exam assesment

 

In order to obtain a course certificate, the student should be able to:

Knowledge

  • analyse the critical unit operations used in manufacturing of small molecule and biologics based medicinal products
  • understand the importance of formulation design in relation to manufacturing according to Quality by Design (QbD) principles
  • demonstrate insight into pharmaceutical quality systems, risk management techniques and plant design of pharmaceutical manufacturing sites

 

Skills

  • perform Design of Experiments (DoE) and multivariate data analysis
  • construct risk assessment of a given pharmaceutical product
  • apply the general principles of physical modelling related to manufacturing of pharmaceuticals.

 

Competences

  • understand the importance of imlementing Quality by Design (QbD) principles into drug development
  • have acquired skills to implement basic elements of QbD into formulation design and manufacturing of a pharmaceutical product